Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GYG | World Class Pump and Dump | 10/07/24 | 166 | 66K | |||
|
|||||||
GYG | Ann: Notification of cessation of securities - GYG | 09/07/24 | 0 | 193 | |||
|
|||||||
GYG | Ann: Change of Director's Interest Notice - T Cowan | 09/07/24 | 0 | 147 | |||
|
|||||||
GYG | Ann: Correction to Directors' Interest Notice | 09/07/24 | 0 | 172 | |||
|
|||||||
GYG | Morningstars Analysis of GYG and IPO price | 08/07/24 | 77 | 22K | |||
|
|||||||
GYG | Ann: Ceasing to be a substantial holder from MUFG | 08/07/24 | 0 | 204 | |||
|
|||||||
GYG | Ann: Ceasing to be a substantial holder | 07/07/24 | 4 | 1.3K | |||
|
|||||||
GYG | Dogs in GYG | 05/07/24 | 1 | 495 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |